Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Mankin

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 12, 2010
Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosisKeinosuke Ryu, Edwin Choy, Cao Yang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 20, 2018
CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma CellsTang Liu, Zuyun Yan, Yong Liu, et al.
Cancer Chemotherapy and Pharmacology|January 7, 2009
RAIDD expression is impaired in multidrug resistant osteosarcoma cell linesCao Yang, Francis J Hornicek, Kirkham B Wood, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2008
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cellsZhenfeng Duan, Rachel Y Ames, Meagan Ryan, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 4, 2018
Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma CellsZheng Xiao, Jia Wan, Ayub Abdulle Nur, et al.
Molecular Cancer Therapeutics|October 1, 2010
Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor traffickingMichiro Susa, Edwin Choy, Xianzhe Liu, et al.
BMC Musculoskeletal Disorders|November 12, 2013
Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffoldPei Yang, Xin Huang, Jacson Shen, et al.
Molecular Cancer Therapeutics|August 9, 2008
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancerZhenfeng Duan, Edward J Weinstein, Diana Ji, et al.
Anti-Cancer Drugs|March 15, 2011
Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivoXianzhe Liu, Edwin Choy, David Harmon, et al.
BMC Cancer|November 18, 2009
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 12, 2010
Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosisKeinosuke Ryu, Edwin Choy, Cao Yang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 20, 2018
CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma CellsTang Liu, Zuyun Yan, Yong Liu, et al.
Cancer Chemotherapy and Pharmacology|January 7, 2009
RAIDD expression is impaired in multidrug resistant osteosarcoma cell linesCao Yang, Francis J Hornicek, Kirkham B Wood, et al.
Cancer Chemotherapy and Pharmacology|July 1, 2008
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cellsZhenfeng Duan, Rachel Y Ames, Meagan Ryan, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 4, 2018
Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma CellsZheng Xiao, Jia Wan, Ayub Abdulle Nur, et al.
Molecular Cancer Therapeutics|October 1, 2010
Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor traffickingMichiro Susa, Edwin Choy, Xianzhe Liu, et al.
BMC Musculoskeletal Disorders|November 12, 2013
Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffoldPei Yang, Xin Huang, Jacson Shen, et al.
Molecular Cancer Therapeutics|August 9, 2008
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancerZhenfeng Duan, Edward J Weinstein, Diana Ji, et al.
Anti-Cancer Drugs|March 15, 2011
Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivoXianzhe Liu, Edwin Choy, David Harmon, et al.
BMC Cancer|November 18, 2009
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcomaMichiro Susa, Arun K Iyer, Keinosuke Ryu, et al.
Pageof 6